Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Newly discovered protein modulates GABA, benzodiazepines

Oct. 17, 2019

Bi-allelic loss of human APC2 is associated with recessive form of lissencephaly

Oct. 17, 2019

Preclinical evaluation of novel nonimmunogenic utrophin gene therapy for DMD

Oct. 17, 2019

Milasen, individualized gene therapy for rare genetic disease

Oct. 17, 2019

Anticoagulants prevent AD symptoms

Oct. 17, 2019

AL-S Pharma initiates phase I study of AP-101 in ALS

Oct. 16, 2019

Pfizer identifies muscarinic acetylcholine M4 receptor agonists

Oct. 16, 2019

New eukaryotic translation initiation factor 2B activators patented by Denali Therapeutics

Oct. 16, 2019

Kappa-opioid receptor antagonists presented by the University of Kansas, University of Florida

Oct. 16, 2019

Yumanity Therapeutics discloses SCD1/SCD5 inhibitors

Oct. 16, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Genescience presents STAT6 degrader for atopic dermatitis
BioWorld Science
Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....
Roche reports new TREM2 agonists
BioWorld Science
F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...